ATM and metabolic disease: Interestingly, Nox2, a key enzyme in the production of ROS, is a driver of the inflammatory and adipocyte-clearing properties of MMe ATM, and ablating Nox2 both improves and worsens DIO-induced metabolic disorders depending on the duration of high-fat feeding [8].